The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Alerian MLP

NYSE: AMLP
Last

(U.S.) $12.17

Today's change-0.02 -0.21%
Updated December 8 11:17 AM -5GMT. Delayed by at least 15 minutes.
 

Alerian MLP

NYSE: AMLP
Last

(U.S.) $12.17

Today's change-0.02 -0.21%
Updated December 8 11:17 AM -5GMT. Delayed by at least 15 minutes.

Alerian MLP crosses below 20-day moving average

Alerian MLP is lower today, dropping (U.S.)$0.03 or 0.21% to (U.S.)$12.17 and crossing below its 20-day moving average. Over the last five days, shares have gained 0.37%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 7.82% during the last year.

Key company metrics

  • Open(U.S.) $12.20
  • Previous close(U.S.) $12.19
  • High(U.S.) $12.25
  • Low(U.S.) $12.16
  • Bid / Ask(U.S.) $12.16 / (U.S.) $12.17
  • YTD % change+0.95%
  • Volume1,247,665
  • Average volume (10-day)8,278,500
  • Average volume (1-month)9,471,649
  • Average volume (3-month)7,838,772
  • 52-week range(U.S.) $7.77 to (U.S.) $13.06
  • Beta0.88
  • Trailing P/E5.89×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield10.83%
  • Trailing EPS(U.S.) $2.06
Updated December 8 11:17 AM -5GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
--

The data is not available to provide analysis on this topic.
Company Books

S&P TSX0.05%Sector:FinancialsIndustry:Investment Trusts

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2013Q2/2013Q4/2012Q2/2012
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedNov 30, 201311/30/2013May 31, 201305/31/2013Nov 30, 201211/30/2012May 31, 201205/31/2012
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense0231711
Selling / general / administrative0231711
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income0-23-17-11
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax332473253-47
Income after tax342482246-29
Income tax, total-11-97-18
Net income342482246-29
Total adjustments to net income--------
Net income before extra. items342482246-29
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items342482246-29
Inc. avail. to common incl. extra. items342482246-29
Diluted net income342482246-29
Dilution adjustment0000
Diluted weighted average shares477358346201
Diluted EPS excluding extraordinary itemsvalue per share0.721.350.71-0.15
Dividends per sharevalue per share0.540.530.510.49
Diluted normalized EPSvalue per share0.721.350.71-0.15